Arkolith/Insider Trading/CSBR/Form 4

Ackerman Joel

DirectorCHAMPIONS ONCOLOGY, INC. (CSBR) · full profile →Form 4 · filed Nov 1, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 31, 2024Option exercise(M)17K$5.43$91K962K
Oct 31, 2024Option exercise(M)88K$2.10$186K945K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 31, 2024Option exercise(M)88K$2.10$186K0
Oct 31, 2024Option exercise(M)17K$5.43$91K0

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-044663) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML